These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 35849604)

  • 1. Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and Disease.
    Richardson WJ; Humphrey SB; Sears SM; Hoffman NA; Orwick AJ; Doll MA; Doll CL; Xia C; Hernandez-Corbacho M; Snider JM; Obeid LM; Hannun YA; Snider AJ; Siskind LJ
    Mol Pharmacol; 2024 Feb; 105(3):131-143. PubMed ID: 38164625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyl chain specificity of ceramide synthases is determined within a region of 150 residues in the Tram-Lag-CLN8 (TLC) domain.
    Tidhar R; Ben-Dor S; Wang E; Kelly S; Merrill AH; Futerman AH
    J Biol Chem; 2012 Jan; 287(5):3197-206. PubMed ID: 22144673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide synthase 2-C
    Zhang X; Sakamoto W; Canals D; Ishibashi M; Matsuda M; Nishida K; Toyoshima M; Shigeta S; Taniguchi M; Senkal CE; Okazaki T; Yaegashi N; Hannun YA; Nabe T; Kitatani K
    FASEB J; 2021 Feb; 35(2):e21287. PubMed ID: 33423335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of restraint stress on ceramide metabolism disorders in the rat liver: the role of CerS6 in hepatocyte injury.
    Liu Y; Sun Z; Sun Q; Wang L; Wang C; Li Y; Ma C; Shi W; Zhang G; Dong Y; Zhang X; Cong B
    Lipids Health Dis; 2024 Mar; 23(1):68. PubMed ID: 38431645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidized phospholipids induce ceramide accumulation in RAW 264.7 macrophages: role of ceramide synthases.
    Halasiddappa LM; Koefeler H; Futerman AH; Hermetter A
    PLoS One; 2013; 8(7):e70002. PubMed ID: 23936132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide Synthases Are Attractive Drug Targets for Treating Metabolic Diseases.
    Raichur S
    Front Endocrinol (Lausanne); 2020; 11():483. PubMed ID: 32849276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and mechanism of a eukaryotic ceramide synthase complex.
    Xie T; Fang Q; Zhang Z; Wang Y; Dong F; Gong X
    EMBO J; 2023 Dec; 42(24):e114889. PubMed ID: 37953642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with relatively broad substrate specificity.
    Mizutani Y; Kihara A; Igarashi Y
    Biochem J; 2006 Sep; 398(3):531-8. PubMed ID: 16753040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterizing a Common CERS2 Polymorphism in a Mouse Model of Metabolic Disease and in Subjects from the Utah CAD Study.
    Nicholson RJ; Poss AM; Maschek JA; Cox JE; Hopkins PN; Hunt SC; Playdon MC; Holland WL; Summers SA
    J Clin Endocrinol Metab; 2021 Jul; 106(8):e3098-e3109. PubMed ID: 33705551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GIMAP5 deficiency reveals a mammalian ceramide-driven longevity assurance pathway.
    Park AY; Leney-Greene M; Lynberg M; Gabrielski JQ; Xu X; Schwarz B; Zheng L; Balasubramaniyam A; Ham H; Chao B; Zhang Y; Matthews HF; Cui J; Yao Y; Kubo S; Chanchu JM; Morawski AR; Cook SA; Jiang P; Ravell JC; Cheng YH; George A; Faruqi A; Pagalilauan AM; Bergerson JRE; Ganesan S; Chauvin SD; Aluri J; Edwards-Hicks J; Bohrnsen E; Tippett C; Omar H; Xu L; Butcher GW; Pascall J; Karakoc-Aydiner E; Kiykim A; Maecker H; Tezcan İ; Esenboga S; Heredia RJ; Akata D; Tekin S; Kara A; Kuloglu Z; Unal E; Kendirli T; Dogu F; Karabiber E; Atkinson TP; Cochet C; Filhol O; Bosio CM; Davis MM; Lifton RP; Pearce EL; Daumke O; Aytekin C; Şahin GE; Aksu AÜ; Uzel G; Koneti Rao V; Sari S; Dalgıç B; Boztug K; Cagdas D; Haskologlu S; Ikinciogullari A; Schwefel D; Vilarinho S; Baris S; Ozen A; Su HC; Lenardo MJ
    Nat Immunol; 2024 Feb; 25(2):282-293. PubMed ID: 38172257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WITHDRAWN: Ceramide synthases in cancer therapy and chemoresistance.
    Brachtendorf S; El-Hindi K; Grösch S
    Prog Lipid Res; 2019 Aug; ():100992. PubMed ID: 31442523
    [No Abstract]   [Full Text] [Related]  

  • 12. Ceramide metabolism in mouse tissue.
    Schiffmann S; Birod K; Männich J; Eberle M; Wegner MS; Wanger R; Hartmann D; Ferreiros N; Geisslinger G; Grösch S
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1886-94. PubMed ID: 23792024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eleven residues determine the acyl chain specificity of ceramide synthases.
    Tidhar R; Zelnik ID; Volpert G; Ben-Dor S; Kelly S; Merrill AH; Futerman AH
    J Biol Chem; 2018 Jun; 293(25):9912-9921. PubMed ID: 29632068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and degradation pathways, functions, and pathology of ceramides and epidermal acylceramides.
    Kihara A
    Prog Lipid Res; 2016 Jul; 63():50-69. PubMed ID: 27107674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian ceramide synthases.
    Levy M; Futerman AH
    IUBMB Life; 2010 May; 62(5):347-56. PubMed ID: 20222015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a ceramide synthase 6 mouse lacking the DDRSDIE C-terminal motif.
    Kim J; Pewzner-Jung Y; Joseph T; Ben-Dor S; Futerman AH
    PLoS One; 2022; 17(7):e0271675. PubMed ID: 35849604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel C-terminal DxRSDxE motif in ceramide synthases involved in dimer formation.
    Kim JL; Ben-Dor S; Rosenfeld-Gur E; Futerman AH
    J Biol Chem; 2022 Feb; 298(2):101517. PubMed ID: 34942147
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.